Cheryl A. Kassed

1.4k total citations
23 papers, 1.0k citations indexed

About

Cheryl A. Kassed is a scholar working on Cancer Research, Cellular and Molecular Neuroscience and Social Psychology. According to data from OpenAlex, Cheryl A. Kassed has authored 23 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cancer Research, 5 papers in Cellular and Molecular Neuroscience and 5 papers in Social Psychology. Recurrent topics in Cheryl A. Kassed's work include NF-κB Signaling Pathways (6 papers), Substance Abuse Treatment and Outcomes (5 papers) and Mental Health Treatment and Access (5 papers). Cheryl A. Kassed is often cited by papers focused on NF-κB Signaling Pathways (6 papers), Substance Abuse Treatment and Outcomes (5 papers) and Mental Health Treatment and Access (5 papers). Cheryl A. Kassed collaborates with scholars based in United States, Switzerland and France. Cheryl A. Kassed's co-authors include Keith R. Pennypacker, Alison E. Willing, Paul R. Sanberg, Katharine R. Levit, Linda Chang, Nora D. Volkow, Joanna S. Fowler, Rita Vandivort-Warren, Tami L. Mark and Miles Herkenham and has published in prestigious journals such as Brain Research, The FASEB Journal and Experimental Neurology.

In The Last Decade

Cheryl A. Kassed

23 papers receiving 990 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cheryl A. Kassed United States 16 258 206 200 198 133 23 1.0k
Kijoung Song United States 14 162 0.6× 377 1.8× 138 0.7× 219 1.1× 148 1.1× 23 1.7k
Jennifer R. Cracchiolo United States 20 285 1.1× 261 1.3× 95 0.5× 286 1.4× 97 0.7× 84 2.0k
Lena Kilander Sweden 25 147 0.6× 437 2.1× 111 0.6× 275 1.4× 140 1.1× 42 1.9k
Gerard Piñol‐Ripoll Spain 24 163 0.6× 373 1.8× 193 1.0× 177 0.9× 43 0.3× 88 1.7k
Suiqiang Zhu China 21 206 0.8× 301 1.5× 205 1.0× 177 0.9× 35 0.3× 98 1.5k
Andrea Arighi Italy 22 234 0.9× 417 2.0× 60 0.3× 297 1.5× 68 0.5× 78 1.4k
Paola Piscopo Italy 22 127 0.5× 628 3.0× 168 0.8× 180 0.9× 43 0.3× 76 1.5k
Yong Zeng China 20 313 1.2× 405 2.0× 72 0.4× 77 0.4× 53 0.4× 78 1.6k
Ru‐Jing Ren China 22 137 0.5× 632 3.1× 83 0.4× 201 1.0× 64 0.5× 54 1.5k
Sun Ah Park South Korea 22 189 0.7× 385 1.9× 112 0.6× 154 0.8× 47 0.4× 72 1.4k

Countries citing papers authored by Cheryl A. Kassed

Since Specialization
Citations

This map shows the geographic impact of Cheryl A. Kassed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheryl A. Kassed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheryl A. Kassed more than expected).

Fields of papers citing papers by Cheryl A. Kassed

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheryl A. Kassed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheryl A. Kassed. The network helps show where Cheryl A. Kassed may publish in the future.

Co-authorship network of co-authors of Cheryl A. Kassed

This figure shows the co-authorship network connecting the top 25 collaborators of Cheryl A. Kassed. A scholar is included among the top collaborators of Cheryl A. Kassed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheryl A. Kassed. Cheryl A. Kassed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jannetto, Paul J., William Clark, Robin J. Hamill-Ruth, et al.. (2018). Executive Summary: American Association of Clinical Chemistry Laboratory Medicine Practice Guideline—Using Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients. The Journal of Applied Laboratory Medicine. 2(4). 489–526. 30 indexed citations
2.
Levit, Katharine R., Cheryl A. Kassed, Michael Coffey, et al.. (2014). Projections of National Expenditures for Mental Health Services and Substance Abuse Treatment. 11 indexed citations
3.
Song, Xue, Stacey R. Long, Beth Barber, et al.. (2012). Systematic Review on Infusion Reactions Associated with Chemotherapies and Monoclonal Antibodies for Metastatic Colorectal Cancer. Current Clinical Pharmacology. 7(1). 56–65. 21 indexed citations
4.
Mark, Tami L., Cheryl A. Kassed, Katharine R. Levit, & Rita Vandivort-Warren. (2012). An Analysis of the Slowdown in Growth of Spending for Psychiatric Drugs, 1986–2008. Psychiatric Services. 63(1). 13–18. 15 indexed citations
5.
Margolis, Jay, Robert Fowler, Barbara H. Johnson, Cheryl A. Kassed, & Kristijan H. Kahler. (2011). Disease-modifying drug initiation patterns in commercially insured multiple sclerosis patients: a retrospective cohort study. BMC Neurology. 11(1). 122–122. 32 indexed citations
6.
Coffey, Rosanna M., Jeffrey A. Buck, Cheryl A. Kassed, et al.. (2008). Transforming Mental Health and Substance Abuse Data Systems in the United States. Psychiatric Services. 59(11). 1257–1263. 8 indexed citations
7.
Mark, Tami L., Cheryl A. Kassed, Rita Vandivort-Warren, Katharine R. Levit, & Henry R. Kranzler. (2008). Alcohol and opioid dependence medications: Prescription trends, overall and by physician specialty. Drug and Alcohol Dependence. 99(1-3). 345–349. 182 indexed citations
8.
Levit, Katharine R., Cheryl A. Kassed, Rosanna M. Coffey, et al.. (2008). Future Funding For Mental Health And Substance Abuse: Increasing Burdens For The Public Sector. Health Affairs. 27(Suppl1). w513–w522. 28 indexed citations
9.
Coffey, Rosanna M., Katharine R. Levit, Cheryl A. Kassed, et al.. (2008). Evidence for Substance Abuse Services and Policy Research. Evaluation Review. 33(2). 103–137. 4 indexed citations
10.
Kassed, Cheryl A., et al.. (2008). Transforming Mental Health and Substance Abuse Data Systems in the United States. Psychiatric Services. 59(11). 1257–1263. 18 indexed citations
11.
Fowler, Joanna S., Nora D. Volkow, Cheryl A. Kassed, & Linda Chang. (2007). Imaging the Addicted Human Brain. PubMed. 3(2). 4–16. 192 indexed citations
12.
Kassed, Cheryl A., et al.. (2007). Hospitalizations Related to Drug Abuse, 2005. 1 indexed citations
13.
Kassed, Cheryl A. & Miles Herkenham. (2004). NF-κB p50-deficient mice show reduced anxiety-like behaviors in tests of exploratory drive and anxiety. Behavioural Brain Research. 154(2). 577–584. 82 indexed citations
14.
Kassed, Cheryl A., et al.. (2003). Mice expressing human mutant presenilin-1 exhibit decreased activation of NF-κB p50 in hippocampal neurons after injury. Molecular Brain Research. 110(1). 152–157. 18 indexed citations
15.
Kassed, Cheryl A., et al.. (2002). Lack of NF-κB p50 Exacerbates Degeneration of Hippocampal Neurons after Chemical Exposure and Impairs Learning. Experimental Neurology. 176(2). 277–288. 82 indexed citations
16.
Butler, Tanya L., Cheryl A. Kassed, Paul R. Sanberg, Alison E. Willing, & Keith R. Pennypacker. (2002). Neurodegeneration in the rat hippocampus and striatum after middle cerebral artery occlusion. Brain Research. 929(2). 252–260. 132 indexed citations
17.
Butler, Tanya L., Cheryl A. Kassed, & Keith R. Pennypacker. (2002). Signal transduction and neurosurvival in experimental models of brain injury. Brain Research Bulletin. 59(5). 339–351. 14 indexed citations
18.
Pennypacker, Keith R., et al.. (2001). NF-κB p50 Is Increased in Neurons Surviving Hippocampal Injury. Experimental Neurology. 172(2). 307–319. 39 indexed citations
19.
Pennypacker, Keith R., et al.. (2000). Expression of fos-related antigen-2 in rat hippocampus after middle cerebral arterial occlusion. Neuroscience Letters. 289(1). 1–4. 25 indexed citations
20.
Pennypacker, Keith R., et al.. (2000). Brain injury: prolonged induction of transcription factors. Acta Neurobiologiae Experimentalis. 60(4). 515–530. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026